Close

Intercept Pharma (ICPT) Granted Accelerated FDA Approval of Ocaliva in PBC

May 30, 2016 10:04 AM EDT Send to a Friend
Late Friday, Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT) announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login